152 related articles for article (PubMed ID: 17071045)
1. Correlation between molecular metastases in sentinel lymph nodes of breast cancer patients and St Gallen risk category.
Gimbergues P; Dauplat MM; Cayre A; Durando X; Le Bouedec G; Finat-Duclos F; Portefaix G; Kwiatkowski F; Dauplat J; Penault-Llorca F; Tchirkov A
Eur J Surg Oncol; 2007 Feb; 33(1):16-22. PubMed ID: 17071045
[TBL] [Abstract][Full Text] [Related]
2. mRNA markers of breast cancer nodal metastases: comparison between mammaglobin and carcinoembryonic antigen in 248 patients.
Marchetti A; Buttitta F; Bertacca G; Zavaglia K; Bevilacqua G; Angelucci D; Viacava P; Naccarato A; Bonadio A; Barassi F; Felicioni L; Salvatore S; Mucilli F
J Pathol; 2001 Sep; 195(2):186-90. PubMed ID: 11592097
[TBL] [Abstract][Full Text] [Related]
3. Detection of MAGE-A3 in breast cancer patients' sentinel lymph nodes.
Wascher RA; Bostick PJ; Huynh KT; Turner R; Qi K; Giuliano AE; Hoon DS
Br J Cancer; 2001 Nov; 85(9):1340-6. PubMed ID: 11720472
[TBL] [Abstract][Full Text] [Related]
4. Genetic detection for micrometastasis in lymph node of biliary tract carcinoma.
Okami J; Dohno K; Sakon M; Iwao K; Yamada T; Yamamoto H; Fujiwara Y; Nagano H; Umeshita K; Matsuura N; Nakamori S; Monden M
Clin Cancer Res; 2000 Jun; 6(6):2326-32. PubMed ID: 10873083
[TBL] [Abstract][Full Text] [Related]
5. Mammaglobin, a potential marker of breast cancer nodal metastasis.
Leygue E; Snell L; Dotzlaw H; Hole K; Troup S; Hiller-Hitchcock T; Murphy LC; Watson PH
J Pathol; 1999 Sep; 189(1):28-33. PubMed ID: 10451484
[TBL] [Abstract][Full Text] [Related]
6. Detection of micrometastases in lymph nodes from patients with breast cancer.
Branagan G; Hughes D; Jeffrey M; Crane-Robinson C; Perry PM
Br J Surg; 2002 Jan; 89(1):86-9. PubMed ID: 11851670
[TBL] [Abstract][Full Text] [Related]
7. Identification of superior markers for polymerase chain reaction detection of breast cancer metastases in sentinel lymph nodes.
Min CJ; Tafra L; Verbanac KM
Cancer Res; 1998 Oct; 58(20):4581-4. PubMed ID: 9788605
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of quantitative reverse transcription-polymerase chain reaction in lymph node-negative esophageal cancer patients.
Godfrey TE; Raja S; Finkelstein SD; Gooding WE; Kelly LA; Luketich JD
Clin Cancer Res; 2001 Dec; 7(12):4041-8. PubMed ID: 11751499
[TBL] [Abstract][Full Text] [Related]
9. Expression of transferrin receptor and ferritin H-chain mRNA are associated with clinical and histopathological prognostic indicators in breast cancer.
Yang DC; Wang F; Elliott RL; Head JF
Anticancer Res; 2001; 21(1B):541-9. PubMed ID: 11299801
[TBL] [Abstract][Full Text] [Related]
10. Impact of cytokeratin-20 and carcinoembryonic antigen mRNA detection by RT-PCR in regional lymph nodes of patients with colorectal cancer.
Rosenberg R; Hoos A; Mueller J; Nekarda H
Br J Cancer; 2000 Nov; 83(10):1323-9. PubMed ID: 11044357
[TBL] [Abstract][Full Text] [Related]
11. Prolactin as a local growth promoter in patients with breast cancer: GCRI experience.
Bhatavdekar JM; Patel DD; Shah NG; Vora HH; Suthar TP; Ghosh N; Chikhlikar PR; Trivedi TI
Eur J Surg Oncol; 2000 Sep; 26(6):540-7. PubMed ID: 11034803
[TBL] [Abstract][Full Text] [Related]
12. Molecular detection of micrometastases and circulating tumor cells in melanoma prostatic and breast carcinomas.
Ghossein RA; Carusone L; Bhattacharya S
In Vivo; 2000; 14(1):237-50. PubMed ID: 10757082
[TBL] [Abstract][Full Text] [Related]
13. [The detection of breast carcinoma micrometastases in axillary lymph nodes by reverse transcriptase-polymerase chain reaction].
Zhang Q; Zhang Y; Gu X; Zhang M; Lin H; Qian H
Zhonghua Wai Ke Za Zhi; 1998 Jul; 36(7):430-2. PubMed ID: 11825433
[TBL] [Abstract][Full Text] [Related]
14. Detection of CK19, CK20 and EGFR mRNAs in peripheral blood of carcinoma patients: correlation with clinical stage of disease.
Gradilone A; Gazzaniga P; Silvestri I; Gandini O; Trasatti L; Lauro S; Frati L; Aglianò AM
Oncol Rep; 2003; 10(1):217-22. PubMed ID: 12469172
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneous expression of MAGE-A genes in occult disseminated tumor cells: a novel multimarker reverse transcription-polymerase chain reaction for diagnosis of micrometastatic disease.
Kufer P; Zippelius A; Lutterbüse R; Mecklenburg I; Enzmann T; Montag A; Weckermann D; Passlick B; Prang N; Reichardt P; Dugas M; Köllermann MW; Pantel K; Riethmüller G
Cancer Res; 2002 Jan; 62(1):251-61. PubMed ID: 11782385
[TBL] [Abstract][Full Text] [Related]
16. Mammaglobin expression in primary, metastatic, and occult breast cancer.
Watson MA; Dintzis S; Darrow CM; Voss LE; DiPersio J; Jensen R; Fleming TP
Cancer Res; 1999 Jul; 59(13):3028-31. PubMed ID: 10397237
[TBL] [Abstract][Full Text] [Related]
17. Detection of epithelial messenger RNA in the plasma of breast cancer patients is associated with poor prognosis tumor characteristics.
Silva JM; Dominguez G; Silva J; Garcia JM; Sanchez A; Rodriguez O; Provencio M; España P; Bonilla F
Clin Cancer Res; 2001 Sep; 7(9):2821-5. PubMed ID: 11555599
[TBL] [Abstract][Full Text] [Related]
18. [Mammaglobin mRNA measurement in the detection of micrometastasis in peripheral blood of breast cancer patients].
Liu N; Zhang W; Shao Y
Zhonghua Zhong Liu Za Zhi; 2001 Jul; 23(4):317-9. PubMed ID: 11783116
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of BRCA2 gene in sporadic breast tumours.
Bièche I; Noguès C; Lidereau R
Oncogene; 1999 Sep; 18(37):5232-8. PubMed ID: 10498873
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of CEA-mRNA expression in peritoneal lavage fluid from patients with gastric cancer.
Tokuda K; Natsugoe S; Nakajo A; Miyazono F; Ishigami S; Hokita S; Takao S; Eizuru Y; Aikou T
Int J Mol Med; 2003 Jan; 11(1):79-84. PubMed ID: 12469223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]